Good morning, and welcome to HealthStream's first quarter 2022 earnings conference call. At this time, I would like to inform you that this conference is being recorded and that all participants are in a listen-only mode. At the request of the company, we will open the conference up for question and answers after the presentation. I will now turn the conference over to Mollie Condra, Vice President, Investor Relations and Communications. Please go ahead, Ms. Condra.
Thank you, and good morning. Thank you for joining us today to discuss our first quarter 2022 results. Also in the conference call with me are Robert A. Frist Jr., CEO and Chairman of HealthStream, and Scotty Roberts, CFO and Senior Vice President. I would also like to remind you that this conference call may contain forward-looking statements regarding future events and the future performance of HealthStream that can involve risks and uncertainties that could cause the actual results to differ materially from those projected in the forward-looking statements. Information concerning these risks and other factors that could cause the results to differ materially from those forward-looking statements are contained in the company's filings with the SEC, including Forms 6-K, 10-Q, and our earnings release. Additionally, we may reference measures such as adjusted EBITDA, which is a non-GAAP financial measure.
A table providing supplemental information on adjusted EBITDA and reconciling to net income attributable to HealthStream is included in the earnings release that we issued yesterday and may refer to in this call. With that start, I'll now turn the call over to CEO Bobby Frist.
Thank you, Molly. Good morning, everyone, and welcome to our first quarter 2022 earnings call. As I reflect on the first quarter, management delivered several key results I'd like to review. First, we did deliver record top-line revenue in the fir st quarter, lapping previous high water marks set in Q1 of 2019 when legacy resuscitation revenue reached a peak of $17.3 million in Q1 of 2019. We have now replaced and grown through that amount with a nearly even mix of organic and inorganic growth strategies. Second, I told you that one of our multi-year goals was to become a higher gross margin company. Our gross margins for Q1 of 2022 were 66.3%, a 750 basis point improvement over Q1 of 2019.
Third, our ecosystem and ecosystem strategy, as reflected in the hStream platform strategy, continues to expand. With hStream subscriptions now at 5.13 million, we believe that our platform strategy is well-positioned for the future. I believe we're delivering on some of the key promises that we've made and our key operational commitments of the last several years. Regarding the macro context for healthcare in the United States, it appears that COVID is significantly tapering off. Last week, the White House COVID czar said the data doesn't point toward another full-on COVID surge because hospitalizations are currently the lowest they've been in the entire pandemic. According to the CDC, the U.S. is currently averaging just over 1,300 hospitalizations per day, which is a pandemic era low point.
This means that our customers are no longer facing the threat of being overrun by COVID patients. This is good news for everyone. In fact, some of our customers are starting to invite sales representatives back on-site as we return to more normalized operations. That said, the longer-term impact of COVID on our customers, and in turn, our businesses are being experienced in ways still being determined, which I'd like to elaborate on. In several areas of our business, we see improving sales environments. In our learning and development application suite, for example, the need for our regulatory compliance solutions appears to have rebounded from pre-pandemic or pandemic-era levels and be steadily increasing. We have a strong sales pipeline in this area and a fully staffed sales team to meet the solid market demand.
At the same time, we're seeing some purchasing hesitancy among Chief Nursing Officers to contract for our elective clinical education products right now, as the stresses on the healthcare professionals persist. Everyone's heard about the unprecedented burnout among staff. According to a recent Fitch Ratings report, resignations in the healthcare and social services sector reached unprecedented levels in 2021, with overall resignations up more than 50% since the start of the pandemic in the U.S. As many hospital CEOs and CNOs are realizing, onboarding, retaining, and engaging the healthcare workforce has never been more important. We believe that HealthStream's products are well-positioned to help solve these problems and that delays based on the need to alleviate burnout and increase retention will ultimately drive sales for the company.
As you think about our results, it's important to remember that our revenue is not expected to be linear over the course of the year. I'd like to point out that overall bookings in the first quarter exceeded our internal expectations, even though our revenue growth for the quarter was just below our annual guidance range. In a subscription SaaS model like ours, the slower bookings we experienced during the height of the pandemic are now showing up in revenue after the fact, and we expect that to persist into the second quarter. That said, we expect our first quarter bookings to begin helping revenues in the last half of the year, which is a key reason that we believe our full-year revenue growth rate will be within our guidance range.
The longer term impact of COVID is also being experienced in our Provider Solutions business with our CredentialStream application. While sales have been strong, the revenue stream for these sales has lagged due to implementation backlog, which has occurred in part due to customers' recent preferences to minimize more change for their staff. Keep in mind that revenue recognition occurs after the CredentialStream application has been fully implemented. Now that our customers are beginning to pick up some of their delayed initiatives, we are hiring more employees to respond to this backlog. For these reasons, we're optimistic that revenue from Provider Solutions will be backloaded in the second half of the year. Our CFO, Scotty Roberts, will talk more about our financial results soon, but I would first like to talk about how management has been able to implement initiatives to reduce expenses while driving employee satisfaction.
Given the encouraging developments regarding the subsiding of COVID in the United States, we announced to our employees on March 14 that everyone is welcome to voluntarily work from one of our offices, which we now call our resource centers, should they want to do that, whether they've been vaccinated or not. HealthStream's transition to a hybrid workplace was initially announced last July and has since that time proven to work very effectively and appears to be highly appreciated by our employees. We determined that our smaller office leases that we inherited through acquisitions were underutilized, and we decided to sunset these offices in favor of the hybrid work practice. This has allowed us to reduce our number of leases from 14 to five, thus reducing our annual G&A expense by approximately $900,000 on an annual basis.
HealthStream, like most other companies, experienced high turnover in the last several quarters, but we've been able to outhire the losses, which has resulted in a net gain of our employee base of over 1,100 employees at the end of the first quarter. We had a net gain of 20 employees in the first quarter of 2022, and a net gain of 15 employees in the fourth quarter of 2021. The strong corporate culture our employees have built is helping us attract and hire fantastic talent. We've also invested in our current employee base to develop qualified and promising employees for higher levels of responsibility and new career trajectories. In fact, I believe in the last 14 or 15 months, we've had over 150 internal promotions.
I think this is really exciting for our workforce and has resulted in generally, very high stability among our leadership team. Before turning over to Scotty, I'd like to comment on our ongoing share repurchase program. We continue to believe that this program is an excellent way to return capital to shareholders. On November 30, 2021, we announced a $20 million share repurchase program, and in March 2022, we completed the full $20 million of repurchases authorized under that program. We then determined to expand our repurchase program, and our board of directors approved an additional $10 million of share buybacks on March 14, 2022. Beginning on March 14 through the end of the quarter, we purchased $5 million worth of shares during the second authorization. That means we entered the second quarter with $5 million still authorized repurchase under the second plan.
Based on our confidence in the company and the value the buybacks will bring to shareholders, I am pleased that our share repurchase program continues to remain in place and active as we progress through the year. In the last segment of the call, I'll elaborate on several exciting business developments, but before I do that, let's turn it over to Scotty Roberts for a more detailed look at the financials.
Good morning, and thanks to everyone listening on today's call. We delivered another solid quarter, achieving year-over-year improvements across the board on our key financial metrics. Revenues were $65.4 million, up 3%. Operating income was $4 million, up 22%. Net income was $2.9 million, up 26%. Earnings per share was $0.09 per share, up 29%. Adjusted EBITDA improved to $14 million, up 3%. Workforce Solutions revenues were $52 million and were up 1.5%, and revenues from Provider Solutions were $13.3 million and were up 9.1%. Excluding the impact of legacy resuscitation revenues, our consolidated revenue growth was 5.8%, and Workforce Solutions revenue growth was 5.1%. The impact of the legacy resuscitation revenues was a decline of $1.7 million this quarter.
For the remainder of the year, we expect the year-over-year declines from legacy resuscitation revenues of $1.1 million in the second quarter, $500,000 in the third quarter, and $300,000 in the fourth quarter. Offsetting this decline, though, are several other products in our portfolio that are contributing to revenue growth, such as the American Red Cross Resuscitation Suite, CredentialStream, Jane, and hStream. With steady growth from products such as these, combined with our M&A investments, quarterly revenues have now lapped the previous high point when the legacy resuscitation products peaked at $17.3 million in the first quarter of 2019. This backfilling of lost revenues was nearly evenly split between organic and inorganic growth. Our gross margin was 66.3% compared to 64.2% last year, coming in ahead of our forecasted gross margin of 65%.
Operating expenses, excluding cost of revenues, were up 5% or $1.9 million and reflect several areas of investment and some expense reductions, which I'll go over. Our investments in product development increased by 9%, which is net of costs capitalized for software development. These investments span our growing product portfolio, including the hStream platform and our three primary application suites, which are learning and development, credentialing and privileging, and scheduling and capacity management. We've also increased investments in sales and marketing, which grew by 16%. This includes additions to staffing, higher sales commissions, and increased marketing expenses. We've previously stated one of our objectives has been to fully staff our scheduling and capacity management sales team. We've grown this sales team from 10 to 26 over the past year, which provides more coverage to grow this new product category for us.
General and administrative expenses declined by 6%, reflecting some planned cost reductions. During the second half of last year, we exited several office leases, as Bobby already mentioned, which are expected to result in about $900,000 of annual savings. In addition, last year, we operated under a transition services agreement associated with the Ansos acquisition, and it was no longer in effect during the first quarter. Finally, another factor that we overcame was a $1 million expense reduction in last year's first quarter associated with changing our paid time off policy. Our adjusted EBITDA was $14 million, increasing by 3%, and adjusted EBITDA margin held constant at 21.4%. We ended the quarter with cash and investment balances of $45.4 million, which was down by $6.6 million since last quarter.
During the quarter, we deployed $19.7 million of cash for share repurchases and $6.9 million for capital expenditures. DSO improved to 45 days compared to 52 days last year. Cash flows from operations were $20.7 million compared to $19.1 million last year. Free cash flows were $13.7 million compared to $11.9 million last year, improving by 15%. It's worth pointing out that we have a higher concentration of billings and collections during the first quarter, causing seasonality in our free cash flows, meaning that free cash flows in the first quarter are likely to be higher than other quarters during the year. The free cash flows that we generated in the quarter were primarily utilized to fund share repurchases.
In total, we spent $19.7 million in cash on share repurchases during the quarter, completing a $20 million repurchase program that began during the fourth quarter of last year. We also expanded the program by $10 million last month and have approximately $5 million remaining as of March 31st. This program will terminate on the earlier of March 13th, 2023, or when the maximum dollar amount under the program has been expended. We may suspend or discontinue making purchases under the program at any time. Now, a quick update on our guidance expectations. We are reiterating our financial guidance issued in February, which is as follows: Consolidated revenues are forecasted to range between $267.5 million and $273 million.
Adjusted EBITDA is forecasted to range between $50 million and $53.5 million, and capital expenditures are forecasted to range between $26 million and $29 million. As I close my comments this morning, I want to reiterate that our planned investments back into the business are essential to our strategy of becoming a single platform company capable of integrating proprietary and third-party applications in a way that increases their value to and adoption by the healthcare market. We look forward to updating you on our progress over the coming quarters. Thanks for your time this morning. Bobby, I'll turn the call back over to you now.
Thank you, Scotty. As part of our business updates, I wanna remind you of how we talk about our business today. We've come a long way since pioneering internet-based training to fill governance, risk, and compliance needs in healthcare. We obviously still do that and actually talked about the strong demand for those services, as we speak. But we also have many new services that we offer and as the business model continues to evolve. As you know, we have been developing a platform strategy as the foundation for our entire enterprise. We call the technology underlying this platform hStream, and increasingly it will enable applications and the platform strategy. We also have three primary application suites. They are learning and development, credentialing and privileging, and scheduling and capacity management.
Let's walk through some updates on hStream, and then I'll give an update on one of the three application areas. Earlier I mentioned that we grew hStream subscription count to 5.13 million during the quarter. Another important way that we grow hStream ecosystem is through adding partners. I want to take a minute to remind you of the various ways hStream platform enables us to add partners. We have a long history of utilizing our 200-person sales team to sell our partners products, which we then deliver through our applications and increasingly through our emerging platform directly. Historically, we also handle all the contract negotiations, billing and collections, and customer support on behalf of our partners.
In this model, which I'll call our traditional partnership model, both customers and partners rely on us to consolidate all of their needs through a single full service platform. This is a thriving model with over 75 active partnerships, and we believe it brings unparalleled benefits to each of those partners and of course to the customers who are recipient of that benefit of 75 fully integrated partners. In recent years, we have expanded our platform approach by offering a new way to partner. This form of partnership is well suited for organizations that prefer to sell and support their own products, but want to take advantage of the benefits of enhancing and delivering their products through our applications and through our emerging platform. We call these hStream-certified partners because they must meet the certification standards we establish for integrating with the hStream platform.
As of today, we currently have eight hStream-certified partners, and we expect this number to grow. hStream-certified partners typically generate lower top-line revenue, but higher margins than traditional partners I initially described. This is because hStream-certified partners bill and collect for their own sales, which means they recognize all the top-line revenue for those sales before remitting a portion of that revenue to HealthStream. The margin to HealthStream on this revenue share is generally high since our service costs are low. This is because the hStream-certified partner, not HealthStream, is responsible for all the sales and support costs associated with their products. Offering both our traditional and hStream-certified partner models has allowed us to grow our marketplace and better serve our customers. It has also allowed us to expand and retain our growing list of partners.
Now, let's move to a quick update on one of our three application suites, Provider Solutions. Approximately three years ago, we announced the launch of CredentialStream, our new SaaS-based application for managing a full spectrum of credentialing, privileging, and enrollment needs in healthcare organizations. For the first quarter of 2022, 42 customer accounts contracted for CredentialStream, averaging about 3.2 new contracts per week. These accounts represent a mix of new customers and existing customers who choose to migrate from our legacy credentialing and privileging platforms to the new CredentialStream application suite. Some of the customers we contracted in the first quarter included University of Iowa Hospitals and Clinics, Washington University Physician Network, Privia Health, and Colorado Care Partners.
We're excited to be gaining adoption of the best-in-class solution our team has built after taking the time to understand and improve the best parts of the legacy solutions we acquired through M&A. On April thirteenth, we announced the promotion of Michael Collier to Executive Vice President, Corporate Strategy and Development. In this role, he will focus on our organic and inorganic growth strategies, particularly in relation to our hStream platform model. During his 10-year tenure at HealthStream, Michael has successfully sourced, negotiated, closed, and helped integrate 14 acquisitions. This has helped originate business models like the hStream Certified Partner program, and I discussed earlier, and has done so while serving as the company's General Counsel and Chief Compliance Officer. His record of accomplishment is impressive, and we're honored to have him step up to this new role on the HealthStream executive team. Congratulations, Michael.
We also made an important addition to our board of directors in the quarter, bringing a high level of healthcare industry expertise and fresh perspective for our growing business. Terry Allison Rappuhn joined HealthStream's board on January 11. She's already making impact with her ideas and insights into the healthcare industry. She also happens to serve as a member of our audit committee. Her extensive board-level experience, which includes serving on six boards, which have been primarily in healthcare, and her executive-level financial expertise, which includes serving as CFO for Coram Healthcare Corporation, make her an outstanding addition to the board. I can promise you, as shareholders, a lot of her questions are about rate of return on invested capital, and free cash flows. In addition to her insights into the healthcare industry and how we can grow our business.
In closing, I'd like to acknowledge our employees' dedication to our corporate value of Streaming Good. Our corporate social responsibility program, which goes by the same name of Streaming Good, is currently actively supporting the American Cancer Society with several engaging activities at this time, which including a virtual 5K walk-run and an executive challenge. Our program has currently raised over $13,000 so far, and we expect to raise even more for the American Cancer Society. It's programs like Streaming Good that differentiate our culture, let us know who we are and how we serve our customers, and what the purpose is to our work. It unifies our workforce and gives us a great energy in going forward to continue to grow the great programs of HealthStream and build great applications like CredentialStream.
Our Streaming Good program is employee-driven, and we all strive to create a positive impact in the communities we serve, including the healthcare industry at large. At this time, I'd like to turn it over for questions from the investor community.
Loren, can you?
Make sure that I was broadcasting. Let's go ahead and open it up for questions if there are any.
Yeah.
At this time, I would like to remind everyone in order to ask a question, please press star one on your telephone keypad. Again, that is star one on your telephone keypad. Your first question comes from the line of Ryan Daniels. Your line is open. You may ask your question.
Yeah, good morning. This is Jared Haase for Ryan. Thanks for taking the question. Yeah, I wanted to follow up on one of the comments from the prepared remarks, specifically that you're seeing some hesitancy around, you know, some of the more elective clinical training products. And, you know, I think burnout was sort of cited as the reason there. Given that burnout is both, I think, a near and a longer-term issue for clinical staff, do you think that some of those headwinds that are impacting that, those products will be temporary, or is that kind of more reflective of the longer-term cadence going forward?
I think they're temporary, and we did try to suss that out in the discussion. It's kind of hard because you look at the temporary impact is just kind of like, whoa, let's just not roll out change if we don't need to. The even the medium and long-term impact is kind of a broader realization that retaining and developing the workforce can be a key differentiator to your competitive advantage or even your survival and growth. We try to hint that while there's kind of a temporary kind of overwhelmed, high turnover, let's change only what we have to mentality. I think the products that can make a difference, either at a lower cost or return time to patients bedside, like we believe our Red Cross program does or our Jane program.
These are a little bit higher cost programs. They do require a change management process, and we have seen some hesitancy in deploying them at the rate that we had seen kind of earlier. That said, I think those are the kinds of solutions that create higher engagement, in the long run, solve the workforce issues instead of contributing to them. There's just kind of an increased sensitivity to burnout and change management right now in some of these elective areas. I do think they're temporary. I think, in fact, I think the more enlightened customers have already begun the investment journey.
Some even acquiring nursing schools, for example, as part of their development strategy. I think in the long run, the roles of education and development and training will be strengthened. Temporarily, I think there's just this, and we all read about and hear about, this general fatigue and those that have gone through this COVID battle and faced that kind of work fatigue.
Got it. Yeah, I think that makes sense. Then, you know, just maybe a quick follow-up. You know, would love to just get, you know, general sort of comments on the sort of health of the end market. I know you kind of alluded to sort of progressing to this new phase of the pandemic, but the labor cost still remains elevated, and that's certainly a problem for hospitals. I think we saw a report last week from one of the large public, you know, hospital operating chains that really kind of magnified that issue and pointing to those labor costs remaining elevated and that taking longer to normalize. Just, you know, would love to kind of get any more color on what you're seeing more broadly in the client base and, you know, how you're kind of working with hospitals to help address the sort of continuing problem of elevated costs.
Certainly, the elevated costs are a real issue. The CEOs of the enlightened health systems are addressing it. They realize they may have to actually invest more to create better retention strategies and pay more to be competitive with, say, the travel agency. At the heart of all this is figuring out how to put these employees at the center of their journey. A lot of our products, like our scheduling program, are being built with that as a philosophy. If you look at our Nursegrid application, it's really taking off organically in the App Store as the No. 1 rated app in the App Store. I think because it allows the nurse to put their work schedule into an app, but also put their social calendar and their desired time off into the app.
They can coordinate with their friends times to meet and greet. What's happening there is that the nurse is becoming the center of the scheduling process, not only driven by, say, business or financial incomes, maybe as in the past. I do think that the labor issues are real, the cost issues are real, the turnover issues are real. The philosophy that HealthStream has is that you have to, you know, attack it head on, develop your workforce, promote them more frequently, invest in their career, and then build smart applications that incorporate their desired personal outcomes into your work and business outcomes, like our new scheduling approach with the Nursegrid application. I think the more of those organizations can do that, the better they'll fight this battle.
They, like everyone, face inflation and these burned-out nurses that realize they can make a lot more and have more flexible lives by working in a travel concept. They're just having to rehire them and invest more in them. It's a really interesting dynamic of kind of recalibrating around higher labor costs, but necessarily investing in that labor cost. Meanwhile, products that save time and money and do it more effectively, like our Red Cross Resuscitation Suite, I think can be a feature of how they combat higher labor costs. I mean, the objective of these organizations to get their employees more time in front of patients. Now, they want them to be competent when they're with patients. You know, you're trading out, you're trying to assess the minimum amount to get the maximum competency at the lowest cost.
I think, again, philosophically, that's the point of HealthStream being a workforce ally through credentialing and privileging, making sure the right people are in the jobs, our scheduling, helping put the nurse at the center of the scheduling process, and our learning and development helps retain and develop over time. I think all three of our core application suites are geared for a future where rising labor costs are a factor, but these are the strategies to combat that for these organizations.
That's perfect. I appreciate all the detail there, and I'll go ahead and hop back in the queue.
Thank you.
Your next question comes from the line of Matt Hewitt. Your line is open. You may ask your question.
Good morning, and congratulations on your progress on several fronts. Maybe the first question for me. You know, it sounds like there is going to be some savings, particularly on the lease side, but it also appears that some of your other operating expense lines came in a little bit lower, at least than we were anticipating, particularly in product development. Was that just a timing issue or now that you've kind of gotten these three major platforms launched and kind of out in the market over the past year to two years, have we kind of fallen back maybe to a little bit lower level?
Well, no, we still have some hiring to do, so I don't wanna say that they're kind of permanently lower. I would say we've had much more attention on G&A. We've had a little cycle now kind of focusing on how we wanna operate post-pandemic. As you heard me say, we've shifted from this concept of offices to resource centers that people can visit and work from, but it's just a different mentality. We're beginning to do our kind of post-COVID adjustments to how we want to operate and finding the areas where we can save money. Another area, for example, is travel costs. Pre-pandemic, we spent about $5 million a year on travel.
We do think c urrently, we're not putting any policy-level restrictions on travel, but we are asking our teams to use the newer technology. Instead of sending, say, four people on site to help close a deal, we may send one senior person on site and everyone else dials in by conference, and everyone now is equipped to do that. We've seen a more intentionality in our selling strategies that don't prohibit travel, but encourage almost a blended selling approach. We haven't put restrictions. Anybody that wants to go and build a relationship with a customer, we're encouraging that, but we're also encouraging to think smarter. In areas like travel and lease expenses, we're seeing us settle in on our post-pandemic kind of operating strategies, which we think can have inherently lower costs.
In the area of product development, you can see that we started to be more successful in hiring. We still have high departure rates like everyone else right now. The Great Resignation is still going on. I'm hearing a little more language about the Great Regret or there's new phrases being bandied about about maybe so much change isn't good for people. We're still in the middle of that, so still the departures. Again, we've had stability in our leadership ranks, and not just relative stability. We've had real stability in our leadership ranks, our top 50 or so officers. We're combating turnover, and like everyone, we're investing in our workforce. This, I mentioned 150 promotions.
The last two quarters, we've had net gains in hiring after several quarters of either flat or down, kind of net losses in our total number of employees. We do need to hire more in tech, and you heard us, so some success in sales. For example, we are building the future application suites in our scheduling capacity management area right now and are trying to do more tech hiring in that area. That said, in CredentialStream, we've seen a relative stabilization of our R&D investments as that application suite takes hold in the market and turns into more regular release cadence, which by the way is really impressive. Our teams' release this morning, I saw a set of nearly 400 enhancements to the CredentialStream platform. These are some minor fixes, repairs.
The R&D investments in CredentialStream have stabilized. They don't have a growth rate on them, but they're steady and they're effective, and that product category is winning market share right now. We feel really good about those investments. Matt, overall, it's a blend of smarter management of G&A, management of a new model for travel and sales. We are investing in targeted areas like product development and scheduling and capacity management. We'll continue to grow in that area, but in other areas that are really important, like credentialing, where, as you pointed, the application is now beyond the launch phase, it's in the acceptance phase, we've b een able to stabilize or even slightly reduce our R&D levels on those products. The blend of all that is very exciting.
It feels like some parts of the portfolio are maturing in their market availability and acceptance, and so we can stabilize our CapEx in those areas. We remain investing in content development. We remain investing and growing investments in scheduling capacity management. Just a lot of ins and outs on that, but I hope that helped provide color on where we're investing and where we're saving.
Very much. That was very helpful. Thank you. Maybe one separate question. Given the portfolio and the platforms that you have today. It was a combination of internal development as well as M&A over the past, you know, several years. As you look out over the next couple of years, do you feel like you have the right pieces in place, at least, from a platform perspective, where M&A maybe isn't going to be as big of a role in kind of building out some of these areas?
As you look out over the next couple of years and given the balance sheet and the strong cash flow, that you're gonna continue to kind of find those tuck-in opportunities to kind of build out some of your platforms a little bit broader? Thank you.
Sure. I think what I would call stabilizing each of our three application areas and getting the investments, the components we need to be successful, we don't feel there's anything missing. There's nothing that we have to do from an M&A standpoint to fulfill the vision for each of those three primary application areas. There's nothing we have to do. That said, the new platform strategy allows for new business opportunities. It allows for the smoother integration of third-party apps. Maybe minority investments or acquiring an app that has a unique competitive advantage and integrating it with our hStream platform would make sense.
You know, M&A will continue to be a part of our strategy and we also talked about ways like our new partnering can be expanded through the platform strategy. We've introduced now and defined a growing partnering program we call hStream Certified Partners. What I would say is that the opportunity for organic and inorganic growth is expanded by our platform capabilities as they expand. It'll be a judgment call in each case on whether it makes sense to build versus buy or launch and develop versus adapt to or integrate with. I guess I would leave all those chips on the table, but say, just make it clear there's nothing that we feel we need to chase or have to do. We'll be thoughtful and careful about the times we choose to build and the times we choose to buy.
That's very helpful. Thank you.
Again, if you would like to ask a question, please press star one on your telephone keypad. Again, that is star one on your telephone keypad. Your next question comes from the line of Vincent Colicchio. Your line is open.
Yeah, Bobby. I'm curious on the hStream Certified Partner program. What does your pipeline look like? Do you expect it to continue to grow in the near term?
We do. It's an active program. We obviously first promote the what we now call the traditional integration program, where we take responsibility for sales, marketing, customer support, fulfillment, and have a higher margin, a higher revenue and then keep and pay a royalty out. The integrated partner program is increasingly interesting because it allows partners to kind of choose where they wanna be on that spectrum. If they want us to help shift market share to their product, they may wanna fully engage with us and let our sales team do their magic in taking their message to market.
If they just want to reach our network, our end users, our 5.1 million end users, they may choose to do their own selling, marketing and support and just simply use our growing ecosystem as a delivery vehicle. Yes, the partner program is now eight, the integrated partner program, it is growing. I expect additional announcements throughout the year, and the revenue streams are growing from that as well. We're solidifying our service model and our growth model there. Without specifically commenting, I would say we intend to grow the number of partners from eight up, and we think it expands. One of the things it does, it allows us to reinforce the marketplace concept because not.
A lot of times these partners will compete in any given category, and so it allows them to choose how they wanna compete. They can use us for distribution, or they can hire, kind of effectively hire our sales and marketing teams to help them move market share. It allows for multiple products per category, makes us more like a marketplace when we can offer integrated partnerships and hStream-certified partnerships. I hope that helps understand. Without specifically reporting, yes, we expect them to grow and in both categories, frankly, as our marketplace strategies take hold.
What are you seeing in terms of pricing on contract renewals? Is the pricing help you offset a meaningful portion of your, you know, your the wage pressures you're seeing?
It's interesting. We have a mixture of pricing strategies. You know, where we have proprietary advantage, like Jane, and we have patents and we have really a market differentiated, highly differentiated product, we have a premium value placed on that product, and I think they deliver premium value to customers. In other areas where it's more important to maintain or bundle, you know, we have a little bit of an Amazon Prime-like strategy with our hStream infrastructure, where the idea is to just get it in place and so sometimes we'll bundle and provide discounts instead of price increases.
It's a judgment call, but we have lots of places where we can drive both types of value, kind of more reach, which expands the ecosystem, and then premium products which have high margins. Just importantly too, some of our new product concepts, like our Workforce Validate, are very inherently high margin products, so we can actually achieve both in that case. We can have a lower market price and still be well positioned for market share gains because our cost of delivering that product is very low. Again, I know that doesn't give you an exact answer, but both strategies are pursued for different products and applications in our ecosystem.
Thanks for the color and thanks for answering my questions.
Thank you, Vincent.
Your next question comes from the line of Ric hard Close. Your line is open.
Yeah, thank you. Can you hear me okay?
Yeah, Richard.
Okay, great. Thanks. Congratulations on the report. Bobby, I apologize I had to jump off the call for a little bit, but I did hear you talk about Privia as a new customer. That seems to be somewhat of a new channel, customer channel for you. Obviously, there's been a lot of activity in that primary care physician marketplace. Can you talk a little bit about the Privia announcement and your thoughts on is that a, you know, good channel for you guys to, you know, expand into?
Yeah. I'll, you know, we obviously created the list to show some diversity of the types of customers we bring in. We have strong teams developing in what we call our continuum markets, which are kind of the non-acute markets for an oversimplification. For most of our product sets, we're beginning to figure out their applicability in additional channels. We haven't really changed our channel definitions that would expand our audience beyond the 10.5 million that were previously defined as opportunities for us. I'm waiting to see if I get a text from the person over that area to see if they want me to add more color about how much they're focusing on that channel. I may or may not get one. I think they're listening in.
I would just say that in general, we're constantly examining the audience, and we're adding sales channel expertise. For example, we've just found that a few of our products are applicable in the nursing school market. We're targeting a couple of hires to begin to test out our products in the nursing school market. When we acquired myClinicalExchange, we got access to the student market as they onboard into hospitals for their rotations. We're now reaching people when they're at school. That would be kind of yet another new onboarding channel way people come into our ecosystem.
In each of these cases, like Privia or the application like myClinicalExchange, which addresses students, we are beginning to hire a few dedicated salespeople in these areas to test them as channels. I'll kind of leave it as that, testing expanded channels like nursing schools and organizations like Privia. Without giving specifics. You know, they're not the bulk of our sales organization yet, but we're testing new channels.
Well, you beat me to the punch on that one. I was gonna ask you about nursing and nursing schools and you have one right across the street from you there. I was curious on that. Can you talk a little bit about nursing in terms of obviously that's been a hard area. You know, what are customers telling you in terms of their thoughts, you know, maybe, you know, how the nursing labor situation sort of plays out maybe over the next year or so?
Oh, gosh, you know, just continued pressure on nursing schools to help create more and interest people in the industry. You know, more creative models for inducing people to become nurses. It's a hard thing because if you talk to any existing nurses, they're all burned out. Even though they're making more money and they're traveling to make more money, you know, there's less team feeling to their jobs, and they're just more stressed. I think each organization is trying to be creative in addressing the true labor challenges of an engaged workforce with mature teams. You know, when you have a team that's 60%-70% travel and they're all new, your clinical effectiveness goes down.
I think it also they're beginning to recognize that labor isn't just a cost issue, it could become a quality issue, you know, with so much change in the workforce. Again, the right organizations are trying to find paths to actually invest to correct that. While there is temporary hesitancy in products like we mentioned, like Jane at scale, we again still see buying, like so we're still selling one Jane contract a week, but the scale isn't as big. They may pilot it more instead of roll it out to the whole workforce. They're looking for strategies like Jane to get people cross-trained more rapidly, engage them in a career development journey. As I mentioned, some are buying nursing schools. They're forming partnership with nursing schools. They're launching creative well-being curriculum.
We started to incorporate into some of our programming some of the well-being topics and curriculum that we have found effective, so they're taking more interest in that dimension of their staff well-being. I think it's a clinical efficacy patient outcome-oriented problem and a labor cost problem as well. They may have articulated the labor cost problem, but if it persists for, you know, a couple of years, they're gonna also, I think, have quality problems.
Mm-hmm.
That's a way of coming back around and saying, well, I think this is all a tailwind for us because at the end of the day, you have to get staff even staff that's gonna turn over faster, you have to get them competent quicker. Like it's not an excuse to say, "Oh, well, I won't invest and train them because if they're only gonna be there nine months," you better make them an effective team member in two months instead of six months.
Mm-hmm.
I think our programs are well positioned to solve these labor problems, but they're real. When I talk to CEOs of health systems, they're trying to find ways to compete with the travel agencies. One other thing we've seen is it's ironic, but the travel agencies are starting to buy our education products and invest in the travel nurses' careers and development. We have a growing list. Speaking of another channel, some of the bigger travel organizations are now customers of our education products. They're actually a little bit more enlightened to the need to train and develop staff, and maybe they can afford it more because they're paying more and billing more to the hospitals. It's an interesting cycle, and I don't have obviously a whole solution, but I think these trends provide tailwind to a lot of our products over time.
Okay, that's very helpful. On the partnerships that you talked about, obviously you guys are attractive from, you know, just the sheer scale of your customer list. I'm just curious, is there any opportunity for you to cross-sell into your partners' existing book of business? Is there from that perspective at all?
It's interesting. I don't think I've really thought about it like that. I would say that we are developing capabilities at the platform level that give us a lot more flexibility on how to provision services. If you used to think of a service as a whole application, like, you know, to build features and an interface, a front end of the application. As we increasingly enhance the hStream platform to include, for example, a growing library of APIs, it does change the engagement model potential. You know, you might find that some of our databases someday become licensable assets that are available through APIs, where people can integrate some of our unique data into their applications or into their intranet or into their EHR.
I do think part of Michael Collier's promotion is to help think through how to monetize some of these new capabilities as they come on board. I don't wanna overrepresent their maturity. They're still relatively immature. But just in general, as we bring, for example, our platform level license service into play, it not only enables products like Workforce Validate, it may enable an organization like a Workday, I guess I'll throw that appeal out there, to directly access the data that underlies that product on a transactional basis. You know, I think the platform strategy opens up the possibilities.
I do wanna be careful not to overrepresent where we are on that curve. We're actively investing to build those. We're working on launching, hopefully this year our w hat we would call our developer portal for the APIs that come with the hStream platform. Once that's open as a toolkit, the economic models for our business, we think evolve. Really excited about that. Again, I don't wanna get too far in front of it. It's a later this year kind of thing, not a right now thing.
Okay. Thank you.
We have a follow-up question from Richard Close. Your line is open.
Great, thanks. Scotty, maybe a question for you. I mentioned I jumped off the call for a little bit, so if you answered this, I apologize. Can you talk a little bit about the EBITDA guidance, obviously the strong performance in the first quarter, just you know, your thoughts in terms of maintaining that guidance for the year?
Sure. I'll try to speak to that, Richard. The first, obviously first quarter came out fairly strong relative to where we kind of tailed off last year. You look at sequential improvements, you know, I think you compare that to what we guided to, you know, the course of the year, you know, we're expecting some of the investments that we've continued to make, you know, increasing our staffing levels, returning to travel, just those are some of the factors that we've, you know, included in our expectations for the remainder of the year. I think, you know, the way it would play out is continued, you know, pressure on the EBITDA. I wouldn't say pressure from a negative perspective. It's, you know, intended, you know, investments.
We'll likely, you know, smooth out and kind of land in the range that we forecasted. You know, another kind of factor that we, you know, have each year is just the labor cost increases that we expect for ourselves that will play out over the course of the year as well.
Okay. Is there any... Are you guys planning your user conference, you know, bringing that back, or is that included at all, or just thoughts there?
I'll have to double-check. We did have a conference last year, although it was virtual. We did bring it back last year in the fourth quarter, and it was virtual. I'm not sure what our plan is for this year, but we can check on that.
Okay. Great. Thank you.
Excuse me, presenters. There are no more phone questions. You may continue.
Thank you. This concludes our earnings conference call. We look forward to our next report to all of you, coming up soon. Thank you very much. Goodbye.
This concludes today's conference call. You may now disconnect.